No effect of Implanon® on inflammatory cardiovascular parameters

Safety of the etonogestrel-releasing implant during the immediate postpartum period: a pilot study

(2009) Milena Bastos Brito et al.   CONTRACEPTION

Comparison of metabolic and inflammatory outcomes in women who used oral contraceptives and the levonorgestrel-releasing intrauterine device in a general population

(2008) Laure Morin-Papunen et al.   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY

Adiponectin: An update

(2008) M. Guerre-Millo   DIABETES & METABOLISM

Effects of the Progestagen-only Contraceptive Implant Implanon®on Transforming Growth Factor β1 and Endothelin-1

(2008) G. Merki-Feld et al.   HORMONE AND METABOLIC RESEARCH

A Comparison of the Short-Term Effects of Oral Conjugated Equine EstrogensVersusTransdermal Estradiol on C-Reactive Protein, Other Serum Markers of Inflammation, and Other Hepatic Proteins in Naturally Menopausal Women

(2008) Jan L. Shifren et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Estrogen replacement therapy decreases plasma adiponectin but not resistin in postmenopausal women

(2008) Anne Kunnari et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Antiandrogenic Contraceptives Increase Serum Adiponectin in Obese Polycystic Ovary Syndrome Patients

(2008) Manuel Luque-Ramírez et al.   Obesity

Effects of non-oral postmenopausal hormone therapy on markers of cardiovascular risk: a systematic review

(2007) M HEMELAAR et al.   FERTILITY AND STERILITY